U.S. SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, D.C. 20549
FORM 12b-25
NOTIFICATION OF LATE FILING
Commission File No. 1-12362
(Check One):
[ ] Form 10-K or Form 10-KSB [ ] Form 20-F [ ] Form 11-K
[ X ] Form 10-Q or Form 10-QSB [ ] Form N-SAR
For Period Ended: December 31, 2002
[ ] Transition Report on Form 10-K or Form 10-KSB
[ ] Transition Report on Form 20-F
[ ] Transition Report on Form 11-K
[ ] Transition Report on Form 10-Q or Form 10-QSB
[ ] Transition Report on Form N-SAR
For the Transition Period Ended:
Nothing in this form shall be construed to imply that the Commission has verified any
information contained herein.
If the notification relates to a portion of the filing checked above, identify the Item(s) to
which the notification relates:
Part I - Registrant Information
Full Name of Registrant: LifePoint, Inc.
Former Name If Applicable: U.S. Drug Testing, Inc.
Address of Principal Executive Office (Street and Number): 1205 South Dupont Street
City, State and Zip Code: Ontario, California 91761
Part II- Rules 12b-25(b) and (c)
If the subject report could not be filed without unreasonable effort or expense and the registrant
seeks relief pursuant to Rule 12b-25(b), the following should be completed.
(Check box if appropriate.)
[ ] (a) The reasons described in reasonable detail in Part III of this form could not be
eliminated without unreasonable effort or expense;
[X](b) The subject annual report, semi-annual report, transition report on Form 10-K
or Form 10-KSB, Form 20-F, 11-K or Form N-SAR, or portion thereof will
be filed on or before the fifteenth calendar day following the prescribed due
date; or the subject quarterly report or transition report on Form 10-Q or
Form 10-QSB, or portion thereof will be filed on or before the fifth calendar
day following the prescribed due date; and
[ ](c) The accountant's statement or other exhibit required by the Rule 12b-25(c) has
been attached if applicable.
Part III - Narrative
State below in reasonable detail the reasons why the Form 10-K and Form 10-KSB, 20-F, 11-K,
10-Q and Form 10-QSB, N-SAR or the transition report or portion thereof could not be filed
within the prescribed time period.
The Registrant's quarterly report on Form 10-Q for the period ending December 31, 2002 cannot
be filed within the prescribed time period as Ernst & Young LLP have not completed their review
of the quarterly results. The Form 10-Q will be filed as soon as reasonably practical and in no
event later than the fifth calendar day following the prescribed due date.
Part IV - Other Information
(1) Name and telephone number of person to contact in regard to this notification.
Michele A. Clark 909 418-3000
(Name) (Area Code) (Telephone Number)
during the preceding 12 months or for such shorter period that the registrant was
required to file such report(s) been filed? If answer is no identify report(s).
[X] Yes [ ] No
corresponding period for the last fiscal year will be reflected by the earnings
statements to be included in the subject report or portion thereof? If so: attach
an explanation of the anticipated change, both narratively and quantitatively,
and, if appropriate, state the reasons why a reasonable estimate of the results
cannot be made. [ ] Yes [X] No
LifePoint, Inc.
(Name of Registrant as specified in charter)
has caused this notification to be signed on its behalf by the undersigned thereunto duly authorized.
Date February 14, 2003
By /s/ Michele A. Clark
Michele A. Clark
Controller and Chief Accounting Officer
